Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.21.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2021
May 12, 2021
Document and Entity Information    
Document Type 10-Q  
Document Period End Date Mar. 31, 2021  
Entity Registrant Name TITAN PHARMACEUTICALS INC  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Title of 12(b) Security Common Stock, par value $0.001  
Trading Symbol TTNP  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   9,864,068
Entity Central Index Key 0000910267  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q1  
Amendment Flag false